In mice bearing CT26 xenografts, PD-1/Tim-3 NVs suppressed tumor growth by 69.0%, remodeled the tumor microenvironment by enhancing CD8+ T cell infiltration and activation, and depleting immunosuppressive regulatory T cells. The gene discussed is HAVCR2; the disease is neoplasm.